Abstract WP19: How Many Patients With Acute Ischemic Stroke Are Eligible to Apply Dawn and Defuse 3 Mismatch Criteria? Results From a Prospective Stroke Center Datebase

Background: Recent clinical trials have proven efficacy of endovascular therapy (EVT) for anterior circulation large vessel occlusion (acLVO). The DAWN and DEFUSE 3 trials have selected patients for EVT beyond 6h from symptom onset. We sought to determine how many patients of our center would qualify to apply advanced DAWN or DEFUSE 3 imaging criteria based on clinical symptoms and imaging with non-contrast CT (NCCT) and CT angiography (CTA)....